{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:33:57Z","timestamp":1789155237554,"version":"build-2803163510"},"reference-count":88,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FIOCRUZ"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PROEP\/CNPq\/Fiocruz"},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"abstract":"<jats:p>BACKGROUND  Leishmaniasis, caused by the protozoan Leishmania, is a neglected tropical disease (NTD) with diverse clinical forms, the most common being cutaneous leishmaniasis (CL). Antileishmanial treatments rely on a small arsenal of chemoherapeutic agents, which are outdated, toxic, and increasingly ineffective due to drug resistance. New antileishmanial treatments and\/or adjunctive therapies are warranted.  OBJECTIVES  Given the role of microbiota in modulating host immunity, we explored whether probiotics (PB8-multistrain probiotic blend, or Lactobacillus rhamnosus GG, LGG-single strain) alone or in combination with the reference drug miltefosine (ML) could improve clinical outcomes against Leishmania amazonensis infection in a BALB\/c mouse model for CL.  METHODS  Mice were administered probiotics [gavage, 109 colony-forming units (CFU)] for a 7-day pre-treatment before infection, followed by another 14-day probiotic treatment with ML co-administration. Paw lesions were measured using a digital calliper, and parasite loads were determined through lesion imprinting and quantitative polymerase chain reaction (qPCR). The potential immunoregulatory effects of probiotic administration on the mouse serum cytokine profiles were investigated via flow cytometry.  FINDINGS AND MAIN CONCLUSIONS  Probiotics alone reduced lesion size slightly, with PB8 achieving a 32% and LGG a 10% reduction at the endpoint (47-50 days post-infection, dpi). The combination of PB8 with a suboptimal ML dose (4 mg\/kg\/day) reduced the lesion size by 74% compared to the vehicle-treated mice, while ML alone achieved 53%. These findings were corroborated by amastigote quantification via imprinting (light microscopy) and qPCR: PB8 plus ML reduced parasite load by 76% and 87%, respectively. Multiplex cytokine analysis [interferon (IFN)-\u03b3, interleukin (IL)-6, IL-10, IL-12p70, tumour necrosis factor (TNF) and chemokine CCL2] showed reduced serum CCL2 in PB8-cotreated groups. This suggests that PB8 could modulate serum cytokine levels to mitigate the risk of excessive inflammation, as elevated CCL2 is linked to disease exacerbation through monocyte recruitment. Our findings demonstrate the potential effect of probiotic administration to enhance antileishmanial efficacy of antiparasitic drugs.<\/jats:p>","DOI":"10.1590\/0074-02760250056","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:54:28Z","timestamp":1763477668000},"source":"Crossref","is-referenced-by-count":1,"title":["The activity of miltefosine combined with oral probiotics in a mouse model of cutaneous leishmaniasis"],"prefix":"10.1590","volume":"120","author":[{"given":"Yevva","family":"Cranshoff","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil; Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Meuser","family":"Batista","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Cristina","family":"Demarque","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberson Donola","family":"Gir\u00e3o","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Faier-Pereira","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Iandra da Silva","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otacilio","family":"Moreira","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Machado","family":"Cascabulho","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila Ferreira","family":"Fiuza","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[{"name":"University of Antwerp,  Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0078-6106","authenticated-orcid":false,"given":"Maria de Nazar\u00e9 Correia","family":"Soeiro","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","year":"2023"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/tropicalmed7040054","article-title":"Immune responses in leishmaniasis an overview","volume":"7","author":"Costa-da-Silva AC","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1017\/S0031182018001014","article-title":"Leishmania, microbiota and sand fly immunity","volume":"145","author":"Martins-da-Silva A","year":"2018","journal-title":"Parasitology"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis current knowledge and future directions","volume":"8","author":"Mann S","year":"2021","journal-title":"Curr Trop Med Rep"},{"key":"ref5"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"123617","DOI":"10.1016\/j.ijpharm.2023.123617","article-title":"Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment Passive and iontophoretic approaches","volume":"648","author":"de S\u00e1 FAP","year":"2023","journal-title":"Int J Pharm"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar J","year":"2012","journal-title":"PLoS One"},{"key":"ref8","first-page":"28","article-title":"An overview of the treatment of cutaneous leishmaniasis","volume":"9","author":"Garza-Tovar TF","year":"2020","journal-title":"Fac Rev"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1590\/0074-02760160557","article-title":"Effect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions","volume":"112","author":"Antonio LF","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2021.03.011","article-title":"Immunotherapy in treatment of leishmaniasis","volume":"233","author":"Akbari M","year":"2021","journal-title":"Immunol Lett"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11095-022-03232-y","article-title":"Current and future strategies against cutaneous parasites","volume":"39","author":"Man E","year":"2022","journal-title":"Pharm Res"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt BM","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"133977","DOI":"10.1016\/j.molstruc.2022.133977","article-title":"Synthetic and medicinal perspective of antileishmanial agents An overview","volume":"1271","author":"Pawar S","year":"2023","journal-title":"J Mol Struct"},{"issue":"26","key":"ref14","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie PM","year":"2016","journal-title":"Vaccine"},{"key":"ref15","year":"2024"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"106459","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","volume":"59","author":"Palic S","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"114165","DOI":"10.1016\/j.ejmech.2022.114165","article-title":"N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents structure-activity relationship exploration and in vivo evaluation","volume":"231","author":"Lin C","year":"2022","journal-title":"Eur J Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"109649","DOI":"10.1016\/j.intimp.2022.109649","article-title":"Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development","volume":"115","author":"Gupta D","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41564-023-01426-7","article-title":"Human microbiome myths and misconceptions","volume":"8","author":"Walker AW","year":"2023","journal-title":"Nat Microbiol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s42003-024-07158-6","article-title":"Cross-comparison of gut metagenomic profiling strategies","volume":"7","author":"Guly\u00e1s G","year":"2024","journal-title":"Commun Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fmicb.2018.01459","article-title":"The gut microbiome as a major regulator of the gut-skin axis","volume":"9","author":"Salem I","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou K","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1115542","DOI":"10.3389\/fcimb.2023.1115542","article-title":"Co-infection of Phlebotomus papatasi (Diptera Psychodidae) gut bacteria with Leishmania major exacerbates the pathological responses of BALB\/c mice","volume":"13","author":"Amni F","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2019.10.004","article-title":"Site specific microbiome of Leishmania parasite and its cross-talk with immune milieu","volume":"216","author":"Misra P","year":"2019","journal-title":"Immunol Lett"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pim.12279","article-title":"Indigenous microbiota and Leishmaniasis","volume":"38","author":"Lopes MEM","year":"2016","journal-title":"Parasite Immunol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10534-010-9298-0","article-title":"Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract","volume":"23","author":"Chen HL","year":"2010","journal-title":"Biometals"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/microorganisms8122018","article-title":"Eukaryotic and prokaryotic microbiota interactions","volume":"8","author":"Kodio A","year":"2020","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.12.011","article-title":"Infection trains the host for microbiota-enhanced resistance to pathogens","author":"Stacy A","year":"2021","journal-title":"Cell"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41579-022-00833-7","article-title":"Microbiota-mediated colonization resistance mechanisms and regulation","volume":"21","author":"Caballero-Flores G","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng D","year":"2020","journal-title":"Cell Res"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.chom.2013.12.010","article-title":"Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2","volume":"15","author":"Kim YG","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"834135","DOI":"10.3389\/fcimb.2022.834135","article-title":"The human skin microbiome in selected cutaneous diseases","volume":"12","author":"Carmona-Cruz S","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"718","key":"ref33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh1469","article-title":"Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity","volume":"15","author":"Farias-Amorim C","year":"2023","journal-title":"Sci Transl Med"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill C","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tifs.2021.04.009","article-title":"Applying probiotics and prebiotics in new delivery formats - is the clinical evidence transferable","volume":"112","author":"Cunningham M","year":"2021","journal-title":"Trends Food Sci Technol"},{"issue":"21","key":"ref36","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.3748\/wjg.v22.i21.5122","article-title":"Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit","volume":"22","author":"Miller LE","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref37","article-title":"The unexplored role of probiotics on the parasitic pathogens","author":"Mukhopadhyay B","year":"2014","journal-title":"Food Nutr Scie"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00436-005-1475-7","article-title":"The treatment of mice with Lactobacillus casei induces protection against Babesia microti infection","volume":"97","author":"Bautista-Garfias CR","year":"2005","journal-title":"Parasitol Res"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/microorganisms8010113","article-title":"Immunobiotic and paraprobiotic potential effect of Lactobacillus casei in a systemic toxoplasmosis murine model","volume":"8","author":"Salas-Lais AG","year":"2020","journal-title":"Microorganisms"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/pathogens11030296","article-title":"Antiparasitic action of Lactobacillus casei ATCC 393 and Lactobacillus paracasei CNCM strains in CD-1 mice experimentally infected with Trichinella britovi","volume":"11","author":"Boros Z","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11686-023-00744-4","article-title":"Evaluating the effect of Lactobacillus casei FEGY 9973 and curcumin on experimental giardiasis","volume":"69","author":"Shady OMA","year":"2024","journal-title":"Acta Parasitol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13104-021-05661-1","article-title":"Evaluation of the effect of probiotic as add-on therapy with conventional therapy and alone in malaria induced mice","volume":"14","author":"Mahajan E","year":"2021","journal-title":"BMC Res Notes"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1017\/S0031182021002079","article-title":"Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents","volume":"149","author":"Santos CC","year":"2022","journal-title":"Parasitology"},{"issue":"2","key":"ref44","first-page":"139","article-title":"The inoculation of Lactobacillus casei in NIH mice induces a protective response against Trypanosoma cruzi (Ninoa strain) infection","volume":"39","author":"Garfias CRB","year":"2008","journal-title":"Vet Mex"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"e01188","DOI":"10.1128\/AAC.01188-20","article-title":"In vitro and in vivo evaluation of an adamantyl-based phenyl sulfonyl acetamide against cutaneous leishmaniasis models of Leishmania amazonensis","volume":"64","author":"Santos CC","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"882555","DOI":"10.3389\/fcimb.2022.882555","article-title":"The impact of the CTHRSSVVC peptide upon experimental models of Trypanosoma cruzi infection","volume":"12","author":"Leite GR","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"ref47","article-title":"Comparison and clinical validation of qPCR assays targeting Leishmania 18S rDNA and HSP70 genes in patients with American tegumentary leishmaniasis","volume":"14","author":"Filgueira CPB","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref48","first-page":"198","article-title":"Interaction of Trypanosoma cruzi with heart muscle cells ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro","volume":"41","author":"Meirelles MN","year":"1986","journal-title":"Eur J Cell Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"108061","DOI":"10.1016\/j.exppara.2020.108061","article-title":"Benznidazole modulates release of inflammatory mediators by cardiac spheroids infected with Trypanosoma cruzi","volume":"221","year":"2021","journal-title":"Exp Parasitol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-9148-8_23","article-title":"Cytometric bead array (CBA) for measuring cytokine levels in Chagas disease patients","volume":"1955","author":"Medeiros NI","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1293\/tox.2014-0049","article-title":"International harmonization of nomenclature and diagnostic criteria (INHAND) progress to date and future plans","volume":"28","author":"Keenan CM","year":"2015","journal-title":"Toxicol Pathol"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan S","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1384244","DOI":"10.3389\/fcimb.2024.1384244","article-title":"Strategies in the drug discovery and development for leishmaniasis immunomodulators, natural products, synthetic compounds, and drug repositioning","volume":"14","author":"de Almeida TF","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1753-4887.2009.00226.x","article-title":"Probiotic microbes do they need to be alive to be beneficial?","volume":"67","author":"Kataria J","year":"2009","journal-title":"Nutr Rev"},{"key":"ref55","article-title":"Probiotic use in clinical practice: what are the risks?","author":"Boyle RJ","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref56","article-title":"The impact of probiotic administration on experimental in vitro and in vivo infection by Trypanosoma cruzi","volume":"120","author":"Batista DGJ","year":"2025","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","article-title":"Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis","volume":"158","author":"Pereira BAS","year":"2008","journal-title":"Vet Parasitol"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-020-06244-z","article-title":"Efficacy of single-strain probiotics versus multi-strain mixtures systematic review of strain and disease specificity","volume":"66","author":"McFarland LV","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ueg2.12636","article-title":"Efficacy and safety of probiotics in IBD an overview of systematic reviews and updated meta-analysis of randomized controlled trials","volume":"12","author":"Estevinho MM","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1472-765x.2000.00590.x","article-title":"The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact delbrueckii subsp. bulgaricus","volume":"30","author":"Ouwehand AC","year":"2000","journal-title":"Lett Appl Microbiol"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AEM.64.11.4573-4580.1998","article-title":"Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB","volume":"64","author":"Coconnier MH","year":"1998","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1128\/AAC.01294-15","article-title":"Different therapeutic outcomes of benznidazole and VNI treatments in different genders in mouse experimental models of Trypanosoma cruzi infection","volume":"59","author":"Guedes-da-Silva FH","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref63","first-page":"1","article-title":"Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA\/2 mice infected with Leishmania mexicana","volume":"84","author":"Satoskar A","year":"1995","journal-title":"Immunology"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/IAI.70.5.2288-2296.2002","article-title":"Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp","volume":"70","author":"Travi BL","year":"2002","journal-title":"Infect Immun"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo TP","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003144","article-title":"Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L major cutaneous leishmaniasis","volume":"8","author":"Fortin A","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"ref67","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.3390\/ijms25105531","article-title":"The development of a one-step RT-qPCR for the detection and quantification of viable forms of Trypanosoma cruzi in acai samples from areas at risk of Chagas disease through oral transmission","volume":"25","author":"Faier-Pereira A","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15287398909531326","article-title":"Carcinogenesis in rats by nitrosodialkylureas containing methyl and ethyl groups given by gavage and in drinking water","volume":"28","author":"Lijinsky W","year":"1989","journal-title":"J Toxicol Environ Health"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/microorganisms9020353","article-title":"Gut-skin axis current knowledge of the interrelationship between microbial dysbiosis and skin conditions","volume":"9","author":"De Pessemier B","year":"2021","journal-title":"Microorganisms"},{"key":"ref70","doi-asserted-by":"crossref","DOI":"10.1293\/tox.26.27S","article-title":"Proliferative and non-proliferative lesions of the rat and mouse integument","author":"Mecklenburg L","year":"2013","journal-title":"J Toxicol Pathol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar A","year":"2019","journal-title":"Front Immunol"},{"issue":"1-3","key":"ref72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-014-8535-y","article-title":"Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms","volume":"59","author":"Martinez PA","year":"2014","journal-title":"Immunol Res"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/IAI.70.4.2151-2158.2002","article-title":"Early enhanced Th1 response after Leishmania amazonensis infection of C57BL\/6 interleukin-10-deficient mice does not lead to resolution of infection","volume":"70","author":"Jones DE","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00436-004-1193-6","article-title":"Immune response induced by New World Leishmania species in C57BL\/6 mice","volume":"94","author":"Maioli TU","year":"2004","journal-title":"Parasitol Res"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4049\/jimmunol.165.1.364","article-title":"IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection","volume":"165","author":"Jones DE","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1389::AID-IMMU1389>3.0.CO;2-1","article-title":"Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level selective impairment of IL-12 induction in Leishmania -infected cells","volume":"28","author":"Belkaid Y","year":"1998","journal-title":"Eur J Immunol"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11686-021-00474-5","article-title":"Identification and characterization of the miRNAs and cytokines in response to Leishmania infantum infection with different response to treatment","volume":"67","author":"Hanif H","year":"2022","journal-title":"Acta Parasitol"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exppara.2010.02.010","article-title":"Role of chemokines in regulation of immunity against leishmaniasis","volume":"126","author":"Oghumu S","year":"2010","journal-title":"Exp Parasitol"},{"issue":"11","key":"ref79","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O","article-title":"Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4","volume":"30","author":"Ritter U","year":"2000","journal-title":"Eur J Immunol"},{"issue":"6","key":"ref80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-3024.2002.00467.x","article-title":"Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis","volume":"24","author":"Ritter U","year":"2002","journal-title":"Parasite Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"155339","DOI":"10.1016\/j.cyto.2020.155339","article-title":"Chemokines in leishmaniasis map of cell movements highlights the landscape of infection and pathogenesis","volume":"147","author":"de Ara\u00fajo FF","year":"2021","journal-title":"Cytokine"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"481750","DOI":"10.1155\/2014\/481750","article-title":"The role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil","volume":"2014","author":"Espir TT","year":"2014","journal-title":"J Immunol Res"},{"key":"ref83","first-page":"1","article-title":"N(6)-methyltubercidin gives sterile cure in a cutaneous Leishmania amazonensis mouse model","author":"Present C","year":"2024","journal-title":"Parasitology"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"105174","DOI":"10.1016\/j.archoralbio.2021.105174","article-title":"Effect of probiotic Lactobacillus rhamnosus by-products on gingival epithelial cells challenged with Porphyromonas gingivalis","volume":"128","author":"Vale GC","year":"2021","journal-title":"Arch Oral Biol"},{"key":"ref85","article-title":"Efficacy of Bifidobacterium animalis subsp. lactis BB-12 against Giardia duodenalis trophozoites: an experimental study","author":"Yuan F","year":"2021","journal-title":"E3S Web Conf"},{"issue":"6","key":"ref86","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1365-2672.1999.00950.x","article-title":"Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801","volume":"87","author":"Zamfir M","year":"1999","journal-title":"J Appl Microbiol"},{"key":"ref87","first-page":"211","article-title":"Giardia and giardiasis an overview of recent developments","author":"Ganguly SGS","year":"2016","journal-title":"CABI"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-1-4939-7033-9_31","article-title":"Identification of effectors precipitation of supernatant material","volume":"1615","author":"Flaugnatti N","year":"2017","journal-title":"Methods Mol Biol"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0074-02762025000101156&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:54:39Z","timestamp":1763477679000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762025000101156&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":88,"alternative-id":["S0074-02762025000101156"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760250056","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e250056"}}